EMERGENCY:Sudden acute chorea in a child — assessment same day or next day, not delayed —call040-46324365immediately — 24 hours, 7 days— 24/7
Chorea is not a disease, it is a sign. The cause determines everything: whether it resolves, progresses, or affects the heart or brain. Expert cause-based diagnosis and treatment at KIMS Neuroscience, Hyderabad.
Involuntary, continuous, flowing, dance-like movements — a symptom, not a disease
Movement Disorders
Children (usually strep-related), adults (genetic, vascular, autoimmune, or drug-related)
Sydenham's Chorea — post-streptococcal autoimmune
Drug-induced, vascular, Huntington's Disease, autoimmune
Neurology · Paediatric Neurology · Neurosurgery
South India is recognised internationally as a high-risk region for Sydenham's Chorea
Chorea is a type of involuntary movement — continuous, irregular, flowing, dance-like jerks that drift unpredictably from one body part to another — caused by disrupted activity in the basal ganglia, the deep brain structures that normally smooth and regulate movement. Chorea is a sign, not a diagnosis. The cause determines everything: whether the movements resolve completely, progress steadily, or affect other organs such as the heart. The most common cause in Indian children is Sydenham's chorea, a post-streptococcal autoimmune condition for which South India is internationally recognised as a high-burden region. In adults the differential is broader — drug-induced, autoimmune (SLE, antiphospholipid syndrome), vascular (stroke), genetic (Huntington's Disease, neuroacanthocytosis, Wilson's), and metabolic causes must each be systematically investigated at KIMS Neuroscience, Hyderabad.
| Fact | Details |
|---|---|
| Definition | Involuntary, continuous, irregular, dance-like movements drifting across the body · A sign, not a diagnosis · Caused by disrupted basal ganglia activity |
| Most common cause (Indian children) | Sydenham's chorea — post-streptococcal autoimmune · Onset typically 1–8 months after a strep throat infection · Peak age 8–9 · Female-to-male 3:1 |
| South India recognition | International consensus guidelines list South India alongside Indigenous Australians as a high-vulnerability population for Sydenham's chorea |
| Heart involvement | Up to 60% of Sydenham's patients develop rheumatic heart valve disease · Echocardiogram mandatory · Long-term penicillin prophylaxis prevents recurrence and protects the heart |
| Bedside signs | Piano-playing fingers · Milkmaid sign · Jack-in-the-box tongue · Motor impersistence · All assessed at KIMS examination |
| Adult chorea — must exclude | Drug-induced (medication review first) · Wilson's Disease (under 50) · SLE / antiphospholipid syndrome (young women) · Huntington's Disease (family history) · Stroke (sudden hemichorea) |
| Treatment of Sydenham's | Penicillin (clear infection) + valproate or carbamazepine (movement control) + IVIG or steroids (severe cases) + long-term penicillin prophylaxis into early adulthood |
| Contact KIMS | 040-44885000 · Same-day paediatric chorea assessment · Emergency: 040-46324365 |
Chorea from the Greek word for "dance" describes a specific type of involuntary movement. It is not tremor (which is rhythmic, back-and-forth shaking). It is not dystonia (which is sustained, twisting posturing). Chorea is a continuous flow of brief, irregular, purposeless movements jerking from one body part to another, never quite following a pattern, constantly shifting. The limbs, face, trunk, fingers, and tongue may all be involved. The movements look almost as though the person is trying to do something, then changing their mind, then starting something else, a restless, flowing, unpredictable activity that the person cannot stop.
Chorea is not a disease. It is a symptom, a sign that something has disrupted the basal ganglia, the deep brain structures that normally regulate and smooth movement. The cause of that disruption can be infectious, autoimmune, genetic, metabolic, vascular, toxic, or drug-related. And the cause determines everything: whether the chorea will resolve completely, whether it will progress, what treatment is needed, and whether other family members are at risk.
At KIMS Neuroscience, Secunderabad, Hyderabad, diagnosing the cause of chorea systematically and promptly is the central clinical task. We do not treat chorea in isolation we find out why it is happening.
Book a Consultation
Speak directly with our specialist team. No referral required. Monday to Saturday.
040-44885000International enquiries: info@kimsneurosciences.comRecognising chorea particularly in a child is the first step. Several clinical features are characteristic:
The fingers move involuntarily, extending and flexing, one after another resembling the movements of someone playing piano keys. This is one of the most recognisable features of chorea in the hands.
When a person with chorea grips the examiner's fingers, their grip strength fluctuates involuntarily squeezing and releasing rhythmically, as if hand-milking a cow. This reflects the inability to sustain voluntary muscle activation because of the continuous involuntary motor activity.
When a person with chorea is asked to protrude their tongue and hold it still, they cannot. The tongue darts in and out of the mouth repeatedly. This is one of the most specific and diagnostically useful signs in childhood chorea.
The inability to maintain any sustained voluntary muscle contraction grip, eye closure, tongue protrusion is a core feature of chorea that distinguishes it from other movement disorders.
The overall picture is of a restless, writhing, involuntary motor activity that the person cannot suppress. In children, this is frequently initially attributed to hyperactivity, fidgeting, clumsiness, or attention problems particularly when the onset is gradual. Initially, doctors may misattribute the restless movements and involuntary facial expressions of Sydenham's chorea to a child being extremely fidgety, hyperactive, clumsy, and purposely uncooperative. Parents, who know their child's baseline, typically recognise that something is different before any clinician does.
The cause of chorea determines the entire management approach. At KIMS, we organise the investigation of chorea around the most likely cause given the patient's age, history, and clinical context.
Sydenham's chorea is a post-infectious autoimmune condition. It occurs when the immune system, responding to a throat infection caused by Group A beta-haemolytic streptococcus (the bacteria responsible for strep throat and scarlet fever), produces antibodies that mistakenly attack the basal ganglia. The result is chorea — typically appearing 1–8 months after the original throat infection, by which time the throat infection itself has often been forgotten. Sydenham's chorea is a major manifestation of rheumatic fever, occurring in up to 40% of patients with rheumatic fever. The incidence is higher in developing countries due to Group A beta-haemolytic streptococcal infection and inadequate treatment, exacerbated by overcrowding and poor hygienic conditions. The incidence of acute rheumatic fever in Asia is 15–21 per 1,000 population — compared to 0.6–0.7 per 1,000 in the United States and Japan. India carries the highest global burden of rheumatic heart disease. And in the most recent international consensus guidelines for Sydenham's chorea, South India is specifically identified alongside Indigenous Australians as a population with recognised high vulnerability to Sydenham's Chorea, warranting a tailored diagnostic approach based on local prevalence. For children in Hyderabad and across Telangana: Sydenham's chorea is not a rare condition. Any child aged 5–15 who develops sudden involuntary movements — particularly if they had a recent sore throat, fever, or joint pains — should be assessed urgently for Sydenham's chorea. Features of Sydenham's chorea: Age: typically 5–15 years; the peak age is 8–9 years; Sydenham's chorea is more prevalent in females than males at a ratio of 3:1 Onset: acute, over hours to days, following a streptococcal throat infection 1–8 months earlier Movement pattern: chorea affecting all four limbs, face, and tongue; may be more prominent on one side (hemichorea) Associated features: hypotonia (reduced muscle tone), emotional lability, obsessive-compulsive thoughts, anxiety, attention difficulties, school deterioration Heart: up to 60% of children with Sydenham's chorea have associated cardiac involvement — rheumatic heart disease affecting the heart valves. Echocardiography is mandatory in every child. Prognosis: most children recover within 3–6 months with treatment, but recurrence is common without antibiotic prophylaxis. Long-term neuropsychiatric effects — OCD, ADHD features, anxiety — are increasingly recognised even after the motor chorea resolves.
Certain medications affect dopamine pathways in the basal ganglia and can cause choreiform movements as a side effect or complication: Levodopa — the main treatment for Parkinson's Disease — can cause "levodopa-induced dyskinesias," which are choreoathetotic movements, particularly after years of treatment Antipsychotic medications — long-term use of dopamine-blocking antipsychotics can cause "tardive dyskinesia," a form of abnormal movement (often orofacial) that may include choreiform features Oestrogen-containing medications — contraceptive pills can rarely trigger chorea, particularly in individuals with a prior history of Sydenham's chorea ("chorea gravidarum" occurs in pregnancy for similar hormonal reasons) Anti-epileptic drugs — phenytoin in particular Metoclopramide (a common anti-nausea drug) — via dopamine blockade Cocaine and amphetamines — stimulant-related chorea Drug-induced chorea is important because it is reversible — withdrawing or adjusting the causative medication typically resolves the movements. At KIMS, every adult presenting with chorea has their medication list reviewed as a priority.
Huntington's Disease is the most common genetic cause of progressive chorea in adults. It is caused by an expansion of the CAG trinucleotide repeat in the HTT gene and is autosomal dominant. Chorea typically begins in the 30s–50s and progressively worsens, accompanied by cognitive decline and psychiatric symptoms. Huntington's Disease and its management are covered in full on our dedicated Huntington's Disease page. In the context of adult chorea investigation, Huntington's Disease genetic testing — CAG repeat analysis — is one of the most important investigations when family history is positive or when no other cause can be found.
Several autoimmune conditions can produce chorea as a neurological complication: Systemic Lupus Erythematosus (SLE) Antiphospholipid Syndrome (APS) Autoimmune encephalitis In any young woman presenting with chorea without a clear cause, SLE and antiphospholipid syndrome must be investigated actively — blood tests including ANA, anti-dsDNA, and antiphospholipid antibodies are part of the routine investigation protocol at KIMS.
A stroke affecting the basal ganglia — particularly the striatum or subthalamic nucleus — can cause hemichorea (chorea on one side of the body only). In older adults, a sudden onset of hemichorea often indicates a stroke or transient ischaemic attack. This is a neurological emergency. Urgent brain imaging — MRI or CT — is required. Small vessel cerebrovascular disease, polycythaemia vera (abnormally high red blood cell count), and non-ketotic hyperglycaemia (very high blood sugar) in diabetic patients can also cause chorea.
Several metabolic conditions can produce chorea: Thyrotoxicosis (overactive thyroid) Hyperglycaemia Hyponatraemia Liver failure These causes are diagnosed with routine blood tests and are reversible with treatment of the underlying metabolic problem.
Beyond Huntington's Disease, other genetic conditions can cause chorea: Wilson's Disease Neuroacanthocytosis Benign hereditary chorea Huntington's Disease-Like syndromes (HDL1, HDL2, HDL3, HDL4) Metabolic genetic conditions — mitochondrial disorders, organic acidurias
Chorea can occur during pregnancy ("chorea gravidarum"), most commonly in women with a prior history of Sydenham's chorea, in the context of antiphospholipid syndrome, or rarely as an isolated hormonal phenomenon. It requires careful investigation and management. In most cases it resolves after delivery or with treatment of the underlying cause.
The specific investigations depend on clinical context — particularly the patient's age, the tempo of onset, and the associated features. At KIMS Neuroscience, the investigation protocol for chorea is systematic and comprehensive:
• Throat swab culture and Group A streptococcal rapid antigen test • Antistreptolysin O (ASO) titre and anti-DNase B — blood tests detecting evidence of recent streptococcal infection • Echocardiogram — mandatory to assess for rheumatic carditis and valve disease • Blood count, inflammatory markers, CRP, ESR • ANA, anti-dsDNA, antiphospholipid antibodies — to exclude autoimmune causes • Brain MRI — to exclude structural causes and assess for basal ganglia signal changes • Thyroid function tests • Wilson's disease screening — ceruloplasmin and 24-hour urinary copper
• Full medication review — immediately • Thyroid function, metabolic panel, blood glucose, liver function • ANA, anti-dsDNA, antiphospholipid antibody panel — SLE and APS investigation • Wilson's disease screening — ceruloplasmin and 24-hour urinary copper (essential in any adult under 50) • Peripheral blood smear — for acanthocytes (neuroacanthocytosis) • Brain MRI — for structural and vascular causes • Huntington's Disease genetic testing (HTT CAG repeat analysis) — when family history is present or no other cause found • Anti-NMDA receptor antibodies and autoimmune encephalitis panel — if the clinical picture suggests autoimmune encephalitis
Treatment is entirely cause-directed. There is no universal "chorea treatment" — the right approach depends on what is causing the chorea.
Eradication of the streptococcal infection: Penicillin (or amoxicillin) to clear any residual streptococcal bacteria. This is the first step — even if the original infection occurred months earlier. Symptomatic control of the chorea: Valproic acid is the first-line medication for controlling choreiform movements in Sydenham's chorea. Carbamazepine is an alternative. Haloperidol or other dopamine-blocking agents are used in severe cases. Immunotherapy for severe cases: Intravenous immunoglobulin (IVIG) or corticosteroids (oral prednisolone) are used in severe or refractory Sydenham's chorea to dampen the autoimmune process. Secondary prophylaxis — long-term penicillin: Monthly intramuscular benzathine penicillin G injections (or daily oral penicillin) for years — typically until early adulthood — prevent recurrence and protect the heart from rheumatic damage.
Withdrawal or dose reduction of the causative medication, supervised carefully, typically resolves the chorea over weeks. In tardive dyskinesia from long-term antipsychotic use, resolution may be slower and sometimes incomplete.
Tetrabenazine (a VMAT2 inhibitor that depletes dopamine) reduces chorea and is the most commonly used medication. Deutetrabenazine is a newer formulation with a better side effect profile. These medications manage symptoms but do not alter disease progression.
Treatment of the underlying condition is primary: • Immunosuppression for lupus • Anticoagulation for antiphospholipid syndrome Symptomatic anti-chorea medications are used alongside for movement control.
Acute stroke management is the priority. Secondary stroke prevention is essential. Symptomatic anti-chorea medications are used if involuntary movements persist.
Correction of the underlying metabolic abnormality resolves chorea in most cases: • Thyroid treatment • Blood glucose control • Sodium correction
Chorea can represent anything from a reversible metabolic problem to a neurological emergency. Recognising when urgent evaluation is needed is critical.
A child has suddenly developed any of the following jerky involuntary movements, clumsiness or dropped objects, an inability to hold their tongue still when asked, writhing or wriggling movements of the hands or face, or a significant personality or mood change particularly following any recent fever, sore throat, or joint pain in the preceding weeks or months.
In Hyderabad and across South India, Sydenham's chorea must be the primary consideration in this clinical picture. Prompt diagnosis and treatment including the echocardiogram to assess the heart can prevent rheumatic heart disease.
Seek urgent assessment if:
An adult has sudden onset of involuntary movements on one side of the body (hemichorea) this may represent a stroke affecting the basal ganglia and warrants urgent imaging.
A person of any age has progressive involuntary movements with no clear diagnosis, a family history of similar movements (particularly in the 30s–50s), or is taking medications that affect dopamine and has developed abnormal movements.
The outcome depends entirely on the cause:
For Sydenham's chorea in children: the movement disorder resolves in most cases within 3–6 months with treatment. The heart must be monitored and protected with long-term antibiotic prophylaxis. Long-term neuropsychiatric effects — including OCD features, anxiety, and attention difficulties — are common even after the visible chorea has gone, and deserve recognition and support.
For drug-induced chorea: usually reversible when the causative drug is stopped or adjusted.
For genetic causes like Huntington's Disease: progressive, managed with symptomatic treatment and support.
For autoimmune and metabolic causes: most patients improve significantly when the underlying condition is treated.
At KIMS Neuroscience, we do not discharge a patient with a diagnosis of "chorea" without a confirmed cause. Every patient leaves with a diagnosis, a treatment plan, a monitoring schedule, and an understanding of what chorea means for their specific situation.
Related Conditions
Chorea is closely linked with several neurological and movement-related conditions that may present with similar symptoms or form part of the differential diagnosis:
Is a child in your family showing sudden, unexplained movements? Don't wait.
Sydenham's chorea — the most common cause of acute chorea in children is highly treatable when diagnosed early. But it also carries a serious risk of heart disease that must be assessed and prevented with the right treatment plan. South India has one of the highest rates of streptococcal-related chorea in the world. At KIMS Neuroscience, Secunderabad, we assess chorea urgently, find the cause, and start the right treatment for both the movement disorder and the heart.
info@kimsneurosciences.com